Fibroblast growth factor receptor:: from chondrodysplasia to bladder cancer

被引：2

作者：

Radvanyi, F ^{[1
]}

Thiéry, JP ^{[1
]}

Billerey, C ^{[1
]}

van der Kwast, TH ^{[1
]}

Zafrani, ÉS ^{[1
]}

Chopin, D ^{[1
]}

机构：

[1] Inst Curie, UMR 144, CNRS, F-75248 Paris 05, France

来源：

M S-MEDECINE SCIENCES | 2001年 / 17卷 / 11期

关键词：

D O I：

10.1051/medsci/200117111189

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：1189 / 1191

页数：3

共 16 条

[1] Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors [J].

Billerey, C ;

Chopin, D ;

Aubriot-Lorton, MH ;

Ricol, D ;

de Medina, SGD ;

Van Rhijn, B ;

Bralet, MP ;

Lefrere-Belda, MA ;

Lahaye, JB ;

Abbou, CC ;

Bonaventure, J ;

Zafrani, ES ;

van der Kwast, T ;

Thiery, JP ;

Radvanyi, F .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :1955-1959

[2]

Bonaventure J, 1996, M S-MED SCI, V12, P44

[3] Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].

Cappellen, D ;

De Oliveira, C ;

Ricol, D ;

de Medina, SGD ;

Bourdin, J ;

Sastre-Garau, X ;

Chopin, D ;

Thiery, JP ;

Radvanyi, F .

NATURE GENETICS, 1999, 23 (01) :18-20

[4] The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts [J].

Chesi, M ;

Nardini, E ;

Lim, RSC ;

Smith, KD ;

Kuehl, WM ;

Bergsagel, PL .

BLOOD, 1998, 92 (09) :3025-3034

[5] Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 [J].

Chesi, M ;

Nardini, E ;

Brents, LA ;

Schrock, E ;

Ried, T ;

Kuehl, WM ;

Bergsagel, PL .

NATURE GENETICS, 1997, 16 (03) :260-264

[6] FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma [J].

Fracchiolla, NS ;

Luminari, S ;

Baldini, L ;

Lombardi, L ;

Maiolo, AT ;

Neri, A .

BLOOD, 1998, 92 (08) :2987-2989

[7] No evidence of somatic FGFR3 mutation in various types of carcinoma [J].

Karoui, M ;

Hofmann-Radvanyi, H ;

Zimmermann, U ;

Couvelard, A ;

Degott, C ;

Faridoni-Laurens, L ;

Ahomadegbe, JC ;

Gazzeri, S ;

Brambilla, E ;

Clerici, T ;

Charbonnier, P ;

Tresallet, C ;

Mitry, E ;

Penna, C ;

Rougier, P ;

Boileau, C ;

Thiery, JP ;

Nordlinger, B ;

Franc, B ;

Radvanyi, F .

ONCOGENE, 2001, 20 (36) :5059-5061

[8] The natural history of bladder cancer - Implications for therapy [J].

Lee, R ;

Droller, MJ .

UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (01) :1-+

[9] A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene [J].

Richelda, R ;

Ronchetti, D ;

Baldini, L ;

Cro, L ;

Viggiano, L ;

Marzella, R ;

Rocchi, M ;

Otsuki, T ;

Lombardi, L ;

Maiolo, AT ;

Neri, A .

BLOOD, 1997, 90 (10) :4062-4070

[10] Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations [J].

Ronchetti, D ;

Greco, A ;

Compasso, S ;

Colombo, G ;

Dell'Era, P ;

Otsuki, T ;

Lombardi, L ;

Neri, A .

ONCOGENE, 2001, 20 (27) :3553-3562

← 1 2 →